Skip to content
drillr.ai
Sign up

VYNE

VYNE Therapeutics Inc.

NASDAQ · Healthcare · Biotechnology · US

$28.56
+0.00%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+16.2%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jul 24, 2026Zeronda Tyler · officer: CHIEF FINANCIAL OFFICERF-InKind22,516$0.90
Jul 24, 2026Domzalski David · director, officer: PRESIDENT AND CEOF-InKind79,391$0.90
Jul 24, 2026Harsch Mutya · officer: CHIEF LEGAL OFFICER AND GCF-InKind22,516$0.90
Jul 24, 2026Stuart Iain · officer: CHIEF SCIENTIFIC OFFICERF-InKind15,405$0.90
Jul 2, 2026Zeronda Tyler · officer: CHIEF FINANCIAL OFFICERF-InKind3,464$0.65
Jul 2, 2026Domzalski David · director, officer: PRESIDENT AND CEOF-InKind12,214$0.65
Jul 2, 2026Harsch Mutya · officer: CHIEF LEGAL OFFICER AND GCF-InKind3,464$0.65
Jul 2, 2026Stuart Iain · officer: CHIEF SCIENTIFIC OFFICERF-InKind2,370$0.65
Jun 2, 2026Domzalski David · director, officer: PRESIDENT AND CEOA-Award30,791$0.31
Apr 2, 2026Stuart Iain · officer: CHIEF SCIENTIFIC OFFICERF-InKind2,876$0.60
Apr 2, 2026Zeronda Tyler · officer: CHIEF FINANCIAL OFFICERF-InKind4,007$0.60
Apr 2, 2026Domzalski David · director, officer: PRESIDENT AND CEOF-InKind14,232$0.60
Apr 2, 2026Harsch Mutya · officer: CHIEF LEGAL OFFICER AND GCF-InKind4,007$0.60
Jan 5, 2026Zeronda Tyler · officer: CHIEF FINANCIAL OFFICERF-InKind7,858$0.58
Jan 5, 2026Harsch Mutya · officer: CHIEF LEGAL OFFICER AND GCF-InKind3,579$0.58
Jan 5, 2026Stuart Iain · officer: CHIEF SCIENTIFIC OFFICERF-InKind2,448$0.58
Jan 5, 2026Domzalski David · director, officer: PRESIDENT AND CEOF-InKind12,684$0.58
Dec 15, 2025Basta Steven L · directorA-Award20,000$0.38
Dec 15, 2025LEPORE PATRICK G · directorA-Award20,000$0.38
Dec 15, 2025Little Elisabeth Sandoval · directorA-Award20,000$0.38
Dec 15, 2025BARBARI SHARON · directorA-Award20,000$0.38
Oct 2, 2025Domzalski David · director, officer: PRESIDENT AND CEOF-InKind12,676$0.34
Oct 2, 2025Stuart Iain · officer: CHIEF SCIENTIFIC OFFICERF-InKind2,453$0.34
Oct 2, 2025Zeronda Tyler · officer: CHIEF FINANCIAL OFFICERF-InKind3,420$0.34
Oct 2, 2025Harsch Mutya · officer: CHIEF LEGAL OFFICER AND GCF-InKind3,581$0.34
Jul 2, 2025Stuart Iain · officer: CHIEF SCIENTIFIC OFFICERF-InKind2,453$1.65
Jul 2, 2025Harsch Mutya · officer: CHIEF LEGAL OFFICER AND GCF-InKind3,581$1.65
Jul 2, 2025Domzalski David · director, officer: PRESIDENT AND CEOF-InKind12,676$1.65
Jul 2, 2025Zeronda Tyler · officer: CHIEF FINANCIAL OFFICERF-InKind3,420$1.65
Jun 3, 2025Harsch Mutya · officer: CHIEF LEGAL OFFICER AND GCA-Award1,145$0.81
Institutional positioning

13F filings over the trailing two quarters

New 14Increased 16Reduced 16Sold out 4
FilerActionSharesFiled
ADAR1 Capital Management, LLCIncreased2,950,000Aug 14, 2026
Nantahala Capital Management, LLCUnchanged2,000,000Aug 19, 2026
NANTAHALA CAPITAL MANAGEMENT, LLCIncreased2,000,000May 15, 2026
LYNX1 CAPITAL MANAGEMENT LPNew Position1,628,700May 4, 2026
Lynx1 Capital Management LPUnchanged1,628,700Aug 13, 2026
SHAY CAPITAL LLCReduced1,610,242May 15, 2026
Shay Capital LLCReduced1,456,651Aug 14, 2026
ANSON FUNDS MANAGEMENT LPReduced1,243,106May 19, 2026
ADAR1 CAPITAL MANAGEMENT, LLCIncreased1,063,899May 18, 2026
T3 Companies, LLCUnchanged945,000Jul 27, 2026
T3 Companies, LLCUnchanged945,000May 7, 2026
BRAIDWELL LPUnchanged916,077Aug 14, 2026
BRAIDWELL LPNew Position916,077May 15, 2026
CITADEL ADVISORS LLCIncreased514,443May 15, 2026
KVP Capital Advisors, LPUnchanged500,551Aug 13, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 24, 2026